Growth hormone and bone.
暂无分享,去创建一个
C. Ohlsson | B. Bengtsson | O. Isaksson | T. Andreassen | O G Isaksson | B A Bengtsson | C Ohlsson | T T Andreassen | M C Slootweg | O. Isaksson | M. Slootweg | T. Andreassen | Olle Isaksson | Maria Slootweg | Claes Ohlsson | Bengt-Åke Bengtsson | Troels T. Andreassen | Maria C. Slootweg | M. Slootweg
[1] R. Whitehouse,et al. Reduced bone mineral density in patients with adult onset growth hormone deficiency. , 1994, The Journal of clinical endocrinology and metabolism.
[2] C. Hanna,et al. Changes in insulin-like growth factor-I (IGF-I), IGF-binding protein-3, growth hormone (GH)-binding protein, erythrocyte IGF-I receptors, and growth rate during GH treatment. , 1995, The Journal of clinical endocrinology and metabolism.
[3] S. Mohan,et al. Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging. , 1994, The Journal of clinical endocrinology and metabolism.
[4] J. M. Harris,et al. Effect of phosphate supplementation, thyrocalcitonin, and growth hormone on strength of fracture healing. , 1975, Surgical forum.
[5] Smith Rw. Dietary and hormonal factors in bone loss. , 1967 .
[6] C. Ohlsson,et al. Embryonic stem cells express growth hormone receptors: regulation by retinoic acid. , 1993, Endocrinology.
[7] J. L. Brande,et al. Effect of growth hormone and peptide fractions containing somatomedin activity on growth and cartilage metabolism of snell dwarfmice. , 1979 .
[8] P. Kelly,et al. The nature of the metabolic bone disorder in acromegaly. , 1972, The Journal of laboratory and clinical medicine.
[9] T. Hansson,et al. Reduced bone mineral content in adult patients with growth hormone deficiency. , 1993, Acta endocrinologica.
[10] M. Haussler,et al. Effect of growth hormone on vitamin D metabolism , 1978, Nature.
[11] F. Talamantes,et al. Stimulation by growth hormone (GH) of GH receptor-associated tyrosine kinase activity. , 1992, Endocrinology.
[12] A. Lindahl,et al. Growth hormone in vivo potentiates the stimulatory effect of insulin-like growth factor-1 in vitro on colony formation of epiphyseal chondrocytes isolated from hypophysectomized rats. , 1987, Endocrinology.
[13] S. Posen,et al. Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism. , 1989, Annals of internal medicine.
[14] A. Saltiel,et al. Stimulation by growth hormone of MAP kinase activity in 3T3-F442A fibroblasts. , 1992, The Journal of biological chemistry.
[15] S. Duursma,et al. Growth hormone is mitogenic for fetal mouse osteoblasts but not for undifferentiated bone cells. , 1988, The Journal of endocrinology.
[16] R. Boyce,et al. Contrasting effects of parathyroid hormone and insulin‐like growth factor I in an aged ovariectomized rat model of postmenopausal osteoporosis , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[17] B. Riggs,et al. Transforming growth factor-beta and forskolin increase all classes of insulin-like growth factor-I transcripts in normal human osteoblast-like cells. , 1995, Biochemical and biophysical research communications.
[18] K. Trzenschik,et al. [Effect of growth hormone on the metabolism of bones and the healing of fractures]. , 1972, Acta chirurgica Academiae Scientiarum Hungaricae.
[19] R. Marcus,et al. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women. , 1997, The Journal of clinical endocrinology and metabolism.
[20] T. Wronski,et al. Time course of vertebral osteopenia in ovariectomized rats. , 1989, Bone.
[21] F. Albright,et al. THE PARATHYROID GLANDS AND METABOLIC BONE DISEASE , 1950, The Ulster Medical Journal.
[22] E. Canalis,et al. Bone morphogenetic protein 2 increases insulin‐like growth factor I and II transcripts and polypeptide levels in bone cell cultures , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[23] D. Bikle,et al. The molecular response of bone to growth hormone during skeletal unloading: regional differences. , 1995, Endocrinology.
[24] C. Hassager,et al. The effect of growth hormone (GH) therapy on urinary pyridinoline cross‐links in GH‐deficient adults , 1991, Clinical endocrinology.
[25] A. Vignery,et al. Evidence of sequential remodeling in rat trabecular bone: Morphology, dynamic histomorphometry, and changes during skeletal maturation , 1984, The Anatomical record.
[26] C. Ohlsson,et al. Growth hormone increases interleukin-6 produced by human osteoblast-like cells. , 1996, The Journal of clinical endocrinology and metabolism.
[27] M. Preece,et al. Effect of bovine growth hormone and a partially pure preparation of somatomedin on various growth parameters in hypopituitary dwarf mice. , 1981, The Journal of endocrinology.
[28] N. Møller,et al. 24-h profile of serum osteocalcin in growth hormone (GH) deficient patients with and without GH treatment. , 1991, Growth regulation.
[29] L. Wilhelmsen,et al. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. , 1997, European journal of endocrinology.
[30] J. Halse,et al. Urinary hydroxyproline excretion in acromegaly. , 1978, Acta endocrinologica.
[31] A. Lindahl,et al. Growth hormone potentiates colony formation of epiphyseal chondrocytes in suspension culture. , 1986, Endocrinology.
[32] C. Ohlsson,et al. Expression of functional growth hormone receptors in cultured human osteoblast-like cells. , 1995, The Journal of clinical endocrinology and metabolism.
[33] T. Wronski,et al. Time course of femoral neck osteopenia in ovariectomized rats. , 1996, Bone.
[34] C. Ohlsson,et al. Growth hormone binds to a single high affinity receptor site on mouse osteoblasts: modulation by retinoic acid and cell differentiation. , 1996, Journal of Endocrinology.
[35] J. Kaufman,et al. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. , 1992, The Journal of clinical endocrinology and metabolism.
[36] E. Canalis,et al. Cortisol inhibits the synthesis of insulin-like growth factor-I in skeletal cells. , 1990, Endocrinology.
[37] A. Flyvbjerg,et al. Growth hormone stimulates bone formation and strength of cortical bone in aged rats , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[38] C. Ohlsson,et al. Elevated levels of growth hormone increase bone mineral content in normal young mice, but not in ovariectomized mice. , 1996, Endocrinology.
[39] S. Shalet,et al. Further increase in forearm cortical bone mineral content after discontinuation of growth hormone replacement , 1995, Clinical endocrinology.
[40] N. Kember. Cell population kinetics of bone growth: the first ten years of autoradiographic studies with tritiated thymidine. , 1971, Clinical orthopaedics and related research.
[41] C. Ohlsson,et al. Clonal analysis of rat tibia growth plate chondrocytes in suspension culture--differential effects of growth hormone and insulin-like growth factor I. , 1994, Growth regulation.
[42] A. Flyvbjerg,et al. Insulin-like growth factor I as a predictor of cortical bone mass in a long-term study of ovariectomized and estrogen-treated rats. , 1996, Bone.
[43] D. Meyer,et al. Growth Hormone Induces a Dna Binding Factor Related to the Interferon-stimulated 91-kda Transcription Factor* Materiazs-3t3-f442a Cells Were Provided , 2022 .
[44] P. Delmas,et al. Serum bone GLA‐protein in growth hormone deficient children , 1986, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[45] M. Ranke,et al. Decreased serum levels of insulin‐like growth factors and IGF binding protein 3 in osteoporosis , 1993, Journal of internal medicine.
[46] Hartmut A. Wollmann,et al. Dose-dependent responses in insulin-like growth factors, insulin-like growth factor-binding protein-3 and parameters of bone metabolism to growth hormone therapy in young adults with growth hormone deficiency. , 1995, Hormone research.
[47] M. Orth,et al. Cortical bone growth and maturational changes in dwarf rats induced by recombinant human growth hormone. , 1996, The American journal of physiology.
[48] S. Mohan,et al. Insulin-like growth factor (IGF)-binding proteins in serum--do they have additional roles besides modulating the endocrine IGF actions? , 1996, The Journal of clinical endocrinology and metabolism.
[49] J. Halse,et al. Total and non-dialyzable urinary hydroxyproline in acromegalics and control subjects. , 1981, Acta endocrinologica.
[50] M. Wood,et al. A biomechanical study of the effects of growth hormone in experimental fracture healing. , 1980, The Journal of bone and joint surgery. British volume.
[51] N. Kember. GROWTH HORMONE AND CARTILAGE CELL DIVISION IN HYPOPHYSECTOMIZED RATS , 1971, Cell and tissue kinetics.
[52] M. Paoli,et al. Bone mineral density of prepubertal age girls with Turner's syndrome while on growth hormone therapy. , 1995, Hormone research.
[53] M. Bolander,et al. Role of Transforming Growth Factor‐β in Fracture Repair , 1990 .
[54] C. Conover,et al. Normal human osteoblast‐like cells consistently express genes for insulin‐like growth factors I and II but transformed human osteoblast cell lines do not , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[55] S. Duursma,et al. Effects of recombinant human insulin-like growth factor I and II (IGF-I/-II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells. , 1991, Growth regulation.
[56] Z. Hochberg,et al. Growth hormone stimulates the growth of mouse neonatal condylar cartilage in vitro. , 1989, Acta endocrinologica.
[57] E. Canalis,et al. Complex pattern of insulin‐like growth factor binding protein expression in primary rat osteoblast enriched cultures: Regulation by prostaglandin E2, growth hormone, and the insulin‐like growth factors , 1994, Journal of cellular physiology.
[58] Koskinen Ev. The repair of experimental fractures under the action of growth hormone, thyrotropin and cortisone. A tissue analytic, roentgenologic and autoradiographic study. , 1959 .
[59] C. Ohlsson,et al. Endocrine regulation of longitudinal bone growth , 1993, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[60] W. Goodman,et al. Skeletal response to recombinant human growth hormone (rhGH) in children treated with long‐term corticosteroids , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[61] R. Marcus,et al. Effects of short term administration of recombinant human growth hormone to elderly people. , 1990, The Journal of clinical endocrinology and metabolism.
[62] R. Deghenghi,et al. Sixteen weeks of hexarelin therapy in aged dogs: effects on the somatotropic axis, muscle morphology, and bone metabolism. , 1996, The journals of gerontology. Series A, Biological sciences and medical sciences.
[63] R. Turner,et al. Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats. , 1995, Endocrinology.
[64] C. Ohlsson,et al. Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells. , 1995, Endocrinology.
[65] J. V. Van Wyk,et al. Stimulation of statural growth by recombinant insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron type) , 1992, The Journal of pediatrics.
[66] J. Jansson,et al. Growth hormone stimulates longitudinal bone growth directly. , 1982, Science.
[67] S. Mohan,et al. The insulin-like growth factor system and the coupling of formation to resorption. , 1995, Bone.
[68] W. O'Fallon,et al. Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. , 1993, The Journal of clinical endocrinology and metabolism.
[69] R. Whitehouse,et al. Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency , 1995, Clinical endocrinology.
[70] J. Aloia,et al. Skeletal metabolism and body composition in acromegaly. , 1972, The Journal of clinical endocrinology and metabolism.
[71] L. Fig,et al. Bone mineral density of the axial skeleton in acromegaly. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[72] R. Marcus,et al. Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. , 1994, The Journal of clinical endocrinology and metabolism.
[73] R. Whitehouse,et al. Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. , 1993, The Journal of clinical endocrinology and metabolism.
[74] E. Canalis,et al. Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. , 1989, The Journal of clinical investigation.
[75] H. Frost,et al. 37 Adrenalcorticosteroid and Salicylate Actions on Human and Canine Haversian Bone Formation and Resorption , 1970, Clinical orthopaedics and related research.
[76] L. Quarles,et al. Prednisone-induced osteopenia in beagles: variable effects mediated by differential suppression of bone formation. , 1992, The American journal of physiology.
[77] T. Wise,et al. Endocrine and metabolite responses to porcine growth hormone administered by sustained release implant for different lengths of time in male pigs. , 1996, Endocrinology.
[78] R. Taylor,et al. Osteoblast-specific expression of growth hormone stimulates bone growth in transgenic mice , 1992, Molecular and cellular biology.
[79] R L Hintz,et al. Insulin-like growth factors I and II: aging and bone density in women. , 1984, The Journal of clinical endocrinology and metabolism.
[80] J M Wit,et al. Effect of gonadectomy on growth and GH responsiveness in dwarf rats. , 1995, The Journal of endocrinology.
[81] C. Wüster. Growth hormone and bone metabolism. , 1993, Acta endocrinologica.
[82] R. Bosch,et al. Changes in bone metabolism during treatment of acromegaly. , 1983, Acta endocrinologica.
[83] T. Martin,et al. Growth hormone (GH) receptors in clonal osteoblast-like cells mediate a mitogenic response to GH. , 1991, Endocrinology.
[84] F. Melsen,et al. The influence of growth hormone on cancellous and cortical bone of the vertebral body in aged rats , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[85] A. Lindahl,et al. Effects of growth hormone and insulin-like growth factor-I on colony formation of rabbit epiphyseal chondrocytes at different stages of maturation. , 1987, Journal of Endocrinology.
[86] T. Andreassen,et al. The stimulating effect of growth hormone on fracture healing is dependent on onset and duration of administration. , 1991, Clinical orthopaedics and related research.
[87] A. Giustina,et al. Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone. , 1995, The Journal of clinical endocrinology and metabolism.
[88] S. M. Russell,et al. Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[89] D. Johnston,et al. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism * , 1994, Clinical endocrinology.
[90] L. Mosekilde,et al. Growth hormone stimulates proliferation of normal human bone marrow stromal osteoblast precursor cells in vitro. , 1994, Growth regulation.
[91] H. Pols,et al. Treatment of post‐menopausal osteoporosis with a combination of growth hormone and pamidronate: a placebo controlled trial , 1995, Clinical endocrinology.
[92] R. Turner. Effects of short-term spaceflight and recombinant human growth hormone (rhGH) on bone growth in young rats. , 1995, Aviation, space, and environmental medicine.
[93] K. Gould,et al. Preservation of bone mass in hypogonadal female monkeys with recombinant human growth hormone administration. , 1992, The Journal of clinical endocrinology and metabolism.
[94] G. Brem,et al. Expression of metallothionein-human growth hormone fusion genes in transgenic mice results in disproportionate skeletal gigantism. , 1991, Growth, development, and aging : GDA.
[95] C. Ohlsson,et al. Disproportional bone growth and reduced weight gain in gonadectomized male bovine growth hormone transgenic and normal mice. , 1994, Endocrinology.
[96] O. Silvennoinen,et al. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase , 1993, Cell.
[97] R. Ziegler,et al. [Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: need for additional growth hormone substitution?]. , 1991, Klinische Wochenschrift.
[98] R. Marcus,et al. Interactions of growth hormone and parathyroid hormone in renal phosphate, calcium, and calcitriol metabolism and bone remodeling in postmenopausal women , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[99] J. Goff,et al. Effects of growth hormone administration on vitamin D metabolism and vitamin D receptors in the pig. , 1990, Domestic animal endocrinology.
[100] D. Heinegård,et al. Human growth hormone enhances chondrogenesis and osteogenesis in a tissue culture system of chondroprogenitor cells. , 1989, Endocrinology.
[101] P. Lips,et al. Histomorphometric analysis of bone mass and bone metabolism in growth hormone deficient adult men. , 1996, Bone.
[102] G. Brem,et al. Growth characteristics of metallothionein-human growth hormone transgenic mice as compared to mice selected for high eight-week body weight and unselected controls. I. Body weight gain and external body dimensions. , 1991, Growth, development, and aging : GDA.
[103] N. Poppen,et al. Normal and abnormal motion of the shoulder. , 1976, The Journal of bone and joint surgery. American volume.
[104] D. Levy,et al. Activation of Acute Phase Response Factor (APRF)/Stat3 Transcription Factor by Growth Hormone (*) , 1995, The Journal of Biological Chemistry.
[105] E. Peters,et al. Insulin-like growth factor I and insulin down-regulate growth hormone (GH) receptors in rat osteoblasts: evidence for a peripheral feedback loop regulating GH action. , 1996, Endocrinology.
[106] D. Schoenfeld,et al. Effects of Physiologic Growth Hormone Therapy on Bone Density and Body Composition in Patients with Adult-Onset Growth Hormone Deficiency , 1996, Annals of Internal Medicine.
[107] K. Ho,et al. Impact of short‐term estrogen administration on growth hormone secretion and action: Distinct route‐dependent effects on connective and bone tissue metabolism , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[108] S. Mohan,et al. Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. , 1991, Biochemical and biophysical research communications.
[109] S. Mohan,et al. Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein-3 and -5, and bone alkaline phosphatase isoenzyme. , 1996, Journal of Clinical Endocrinology and Metabolism.
[110] S. Ljunghall,et al. Low plasma levels of insulin‐like growth factor 1 (IGF‐1) in male patients with idiopathic osteoporosis , 1992, Journal of internal medicine.
[111] E. Wolf,et al. The GH-transgenic mouse as an experimental model for growth research: clinical and pathological studies. , 1992, Hormone research.
[112] F. Melsen,et al. Iliac crest bone mass and remodelling in acromegaly. , 1981, Acta endocrinologica.
[113] R. Marcus,et al. Effects of recombinant insulin‐like growth factor‐I and growth hormone on bone turnover in elderly women , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[114] H. Sjöberg,et al. Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. , 1992, Acta endocrinologica.
[115] H. Oxlund,et al. Anabolic effects of parathyroid hormone and growth hormone on vertebral body cortical and cancellous bone in old ovariectomized rats. , 1996 .
[116] A. Sommer,et al. Systemic administration of rhIGF-I or rhIGF-I/IGFBP-3 increases cortical bone and lean body mass in ovariectomized rats. , 1995, Bone.
[117] R. Marcus,et al. Turner syndrome adolescents receiving growth hormone are not osteopenic. , 1993, The Journal of clinical endocrinology and metabolism.
[118] H. Frost,et al. On the rat model of human osteopenias and osteoporoses. , 1992, Bone and mineral.
[119] J. Aloia,et al. Skeletal alterations in hypophysectomized rats: I. A histomorphometric study on tibial cancellous bone , 1995, The Anatomical record.
[120] M. Bolander,et al. Role of transforming growth factor-beta in fracture repair. , 1990, Annals of the New York Academy of Sciences.
[121] E. Froesch,et al. Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I. , 1988, Biochemical and biophysical research communications.
[122] A. Schulz,et al. Effect of growth hormone on osteoblasts and demonstration of somatomedin-C/IGF I in bone organ culture. , 1984, Acta endocrinologica.
[123] T. Andreassen,et al. The effect of growth hormone on fracture healing in old rats. , 1991, Bone.
[124] J. Beresford,et al. Osteoblasts and osteoclasts in adult human osteophyte tissue express the mRNAs for insulin-like growth factors I and II and the type 1 IGF receptor. , 1995, Bone.
[125] P. Lips,et al. Consequences of childhood‐onset growth hormone deficiency for adult bone mass , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[126] A. Klibanski,et al. Effects of rhIGF-I administration on bone turnover during short-term fasting. , 1995, The Journal of clinical investigation.
[127] C. Ohlsson,et al. Cortisol decreases IGF-I mRNA levels in human osteoblast-like cells. , 1996, The Journal of endocrinology.
[128] B. Riggs,et al. Transforming Growth Factor-β and Forskolin Increase All Classes of Insulin-like Growth Factor-I Transcripts in Normal Human Osteoblast-like Cells , 1995 .
[129] W. Millard,et al. Effect of growth hormone administration and treadmill exercise on serum and skeletal IGF-I in rats. , 1994, The American journal of physiology.
[130] D. Johnston,et al. Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults * , 1995, Clinical endocrinology.
[131] A. Hansson,et al. Growth hormone (GH) induction of tyrosine phosphorylation and activation of mitogen-activated protein kinases in cells transfected with rat GH receptor cDNA. , 1992, The Journal of biological chemistry.
[132] N. Skakkebaek,et al. Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3, bone isoenzyme alkaline phosphatase and forearm bone mineral content in young adults with GH deficiency of childhood onset. , 1994, European journal of endocrinology.
[133] K. Kivirikko,et al. Action of growth hormone on the metabolism of collagen in the rat. , 1968, Biochemical pharmacology.
[134] M. White,et al. Growth Hormone, Interferon-γ, and Leukemia Inhibitory Factor Promoted Tyrosyl Phosphorylation of Insulin Receptor Substrate-1 (*) , 1995, The Journal of Biological Chemistry.
[135] H. Pols,et al. Combined treatment of growth hormone and the bisphosphonate pamidronate, versus treatment with GH alone, in GH‐deficient adults: the effects on renal phosphate handling, bone turnover and bone mineral mass , 1995, Clinical endocrinology.
[136] H. Green,et al. A dual effector theory of growth-hormone action. , 1985, Differentiation; research in biological diversity.
[137] R. Smith. Dietary and hormonal factors in bone loss. , 1967, Federation proceedings.
[138] R. de Groot,et al. Growth hormone induces expression of c-jun and jun B oncogenes and employs a protein kinase C signal transduction pathway for the induction of c-fos oncogene expression. , 1991, Journal of molecular endocrinology.
[139] J. Aloia,et al. Effects of growth hormone in osteoporosis. , 1976, The Journal of clinical endocrinology and metabolism.
[140] G. Saggese,et al. Effects of growth hormone on phosphocalcium homeostasis and bone metabolism. , 1995, Hormone research.
[141] B. Hollis,et al. Effect of growth hormone on bone: Bone mineral density, trabecular bone volume, and alkaline phosphatase improve or are restored in the dwarf rat treated with growth hormone , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[142] S. Duursma,et al. The presence of classical insulin-like growth factor (IGF) type-I and -II receptors on mouse osteoblasts: autocrine/paracrine growth effect of IGFs? , 1990, The Journal of endocrinology.
[143] D. Bikle,et al. Skeletal unloading induces selective resistance to the anabolic actions of growth hormone on bone , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[144] J. Salles,et al. Dexamethasone increases and serum decreases growth hormone receptor binding to UMR-106.01 rat osteosarcoma cells. , 1994, Endocrinology.
[145] T. Andreassen,et al. Mechanical properties and biochemical composition of rat cortical femur and tibia after long-term treatment with biosynthetic human growth hormone. , 1991, Bone.
[146] A. Lindahl,et al. Differential effects of growth hormone and insulin-like growth factor I on colony formation of epiphyseal chondrocytes in suspension culture in rats of different ages. , 1987, Endocrinology.
[147] L. Wilkins. Voluntary Medical Care Insurance in the United States , 1949 .
[148] R. Erben,et al. Trabecular and endocortical bone surfaces in the rat: Modeling or remodeling? , 1996, The Anatomical record.
[149] S. Ott. Attainment of peak bone mass. , 1990, The Journal of clinical endocrinology and metabolism.
[150] L. Mosekilde,et al. Short‐term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: A dose response study , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[151] H. Green,et al. The generation of insulin-like growth factor-1--sensitive cells by growth hormone action. , 1986, Science.
[152] J. Reynolds,et al. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function. , 1995, Endocrinology.
[153] S. Feld,et al. Growth hormone, the insulin-like growth factor system, and the kidney. , 1996, Endocrine reviews.
[154] A. Sartorio,et al. Growth hormone treatment in adults with GH deficiency: Effects on new biochemical markers of bone and collagen turnover , 1993, Journal of endocrinological investigation.
[155] T. Andreassen,et al. Dose response of growth hormone on fracture healing in the rat. , 1990, Acta orthopaedica Scandinavica.
[156] A. Klibanski,et al. Osteopenia in men with a history of delayed puberty. , 1992, The New England journal of medicine.
[157] W. J. Johnson,et al. Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. , 1982, The Journal of clinical investigation.
[158] P. Aspenberg,et al. Modification of bone formation rate by growth hormone, melanocyte-stimulating hormone, and cortisone in the normal rat. , 1985, Acta Anatomica.
[159] S. Ljunghall,et al. Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis. , 1996, The Journal of clinical endocrinology and metabolism.
[160] S. Mohan,et al. Studies on regulation of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-4 production in human bone cells. , 1992, Acta endocrinologica.
[161] J. Hock,et al. Anabolic effect of human synthetic parathyroid hormone-(1-34) depends on growth hormone. , 1990, Endocrinology.
[162] P. Rotwein,et al. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. , 1989, Endocrine reviews.
[163] S. Mohan,et al. Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: a potential local regulator of IGF action. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[164] E. Lesaffre,et al. Relationship Between Baseline Insulin‐Like Growth Factor‐I (IGF‐I) and Femoral Bone Density in Women Aged Over 70 Years: Potential Implications for the Prevention of Age‐Related Bone Loss , 1996, Journal of the American Geriatrics Society.
[165] B. Riggs,et al. The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-beta. , 1994, The Journal of clinical endocrinology and metabolism.
[166] F. Albright,et al. The Parathyriod Glands and Metabolic Bone Disease. , 1948 .
[167] R T Turner,et al. The effects of ovariectomy and 17β‐estradiol on cortical bone histomorphometry in growing rats , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[168] J R Florini,et al. Growth hormone and the insulin-like growth factor system in myogenesis. , 1996, Endocrine reviews.
[169] E. Canalis,et al. Transcriptional repression of insulin-like growth factor I by glucocorticoids in rat bone cells. , 1995, Endocrinology.
[170] M. Waters,et al. Cellular localization of the growth hormone binding protein in the rat. , 1992, Endocrinology.
[171] D. Johnston,et al. The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults * , 1995, Clinical endocrinology.
[172] N. Kember. Cell Kinetics and the Control of Growth In Long Bones , 1978, Cell and tissue kinetics.
[173] L. Mosekilde,et al. No evidence for reduced spontaneous or growth-hormone-stimulated serum levels of insulin-like growth factor (IGF)-I, IGF-II or IGF binding protein 3 in women with spinal osteoporosis. , 1994, European journal of endocrinology.
[174] S. Lamberts,et al. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition , 1992, Clinical endocrinology.
[175] N. Kember,et al. Control of Bone Growth in Rats , 1971, Nature.
[176] E. Spencer,et al. The mechanism of the action of growth hormone on vitamin D metabolism in the rat. , 1981, Endocrinology.
[177] R. Brommage,et al. Benefit of systemically administered rhIGF‐I and rhIGF‐I/IGFBP‐3 on cancellous bone in ovariectomized rats , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[178] D. Kalu,et al. Evaluation of the pathogenesis of skeletal changes in ovariectomized rats. , 1984, Endocrinology.
[179] P. Aspenberg,et al. No effect of growth hormone on bone graft incorporation. Titanium chamber study in the normal rat. , 1994, Acta orthopaedica Scandinavica.
[180] Z. Laron,et al. Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism , 1992, The Lancet.
[181] Michael G. Rosenfeld,et al. Dramatic growth of mice that develop from eggs microinjected with metallothionein–growth hormone fusion genes , 1982, Nature.
[182] C H Turner,et al. Basic biomechanical measurements of bone: a tutorial. , 1993, Bone.
[183] S. Duursma,et al. Direct stimulatory effect of growth hormone on DNA synthesis of fetal chicken osteoblasts in culture. , 1988, Acta endocrinologica.
[184] D. Kalu. The ovariectomized rat model of postmenopausal bone loss. , 1991, Bone and mineral.
[185] T. Andreassen,et al. Growth hormone promotes healing of tibial fractures in the rat. , 1991, Acta orthopaedica Scandinavica.
[186] A. Stiles,et al. Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[187] G. Saggese,et al. In vitro effects of growth hormone and other hormones on chondrocytes and osteoblast‐like cells , 1993, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[188] M. Blackman,et al. Human growth hormone and human aging. , 1993, Endocrine reviews.
[189] Z. Laron,et al. IGF-I treatment of adult patients with Laron syndrome: preliminary results. , 1994, Clinical endocrinology.
[190] S. Ljunghall,et al. The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin‐like growth factor I , 1992, Journal of internal medicine.
[191] G. Rodan,et al. Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional control. , 1991, Molecular endocrinology.
[192] E. Froesch,et al. Release of insulin-like growth factor carrier proteins by osteoblasts: stimulation by estradiol and growth hormone. , 1989, Biochemical and biophysical research communications.
[193] J. Aloia,et al. Treatment of osteoporosis with calcitonin, with and without growth hormone. , 1985, Metabolism: clinical and experimental.
[194] E. J. V. van Zoelen,et al. Characterization of growth factor activity produced by fetal mouse osteoblasts. , 1990, The Journal of endocrinology.
[195] S. Souza,et al. Growth hormone stimulates tyrosine phosphorylation of insulin receptor substrate-1. , 1994, The Journal of biological chemistry.
[196] A. Pasquino,et al. Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long-term growth hormone therapy. , 1995, European journal of endocrinology.
[197] C. Carella,et al. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. , 1993, The Journal of clinical endocrinology and metabolism.
[198] R. Palmiter,et al. Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice. , 1990, Endocrinology.
[199] J. Salles,et al. Growth hormone induces tyrosine phosphorylation of annexin I in rat osteosarcoma cells. , 1996, Endocrinology.
[200] R. Palmiter,et al. Growth enhancement of transgenic mice expressing human insulin-like growth factor I. , 1988, Endocrinology.
[201] L. Mosekilde,et al. Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. , 1996, The Journal of clinical endocrinology and metabolism.
[202] E. Spencer,et al. Local injections of human or rat growth hormone or of purified human somatomedin-C stimulate unilateral tibial epiphyseal growth in hypophysectomized rats. , 1985, Endocrinology.
[203] G. Rodan,et al. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. , 1990, Endocrinology.
[204] J. Tobias,et al. Growth hormone deficiency during puberty reduces adult bone mineral density. , 1992, Archives of disease in childhood.
[205] E. Hunziker,et al. Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo. , 1994, The Journal of clinical investigation.
[206] C. Löwik,et al. Osteoclast formation together with interleukin-6 production in mouse long bones is increased by insulin-like growth factor-I. , 1992, The Journal of endocrinology.
[207] B. Bloch,et al. Growth hormone-deficient dwarfism in the rat: a new mutation. , 1988, The Journal of endocrinology.
[208] B. Bengtsson,et al. Serum insulin‐like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin , 1994, Clinical endocrinology.
[209] Elizabeth J. Robertson,et al. Role of insulin-like growth factors in embryonic and postnatal growth , 1993, Cell.
[210] M. Thorén,et al. Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy. , 1995, European journal of endocrinology.
[211] R. Heaney,et al. Effect of Growth Hormone on Skeletal Mass in Adult Dogs , 1969, Nature.
[212] P. Backeljauw,et al. Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome--a clinical research center study. GHIS Collaborative Group. , 1996, The Journal of clinical endocrinology and metabolism.
[213] S. Ljunghall,et al. Insulin-like growth factor I stimulates bone turnover in osteoporosis , 1992, The Lancet.
[214] E. Canalis. Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. , 1996, The Journal of clinical endocrinology and metabolism.
[215] D. Bolt,et al. Erythroid-specific expression of human growth hormone affects bone morphology in transgenic mice. , 1996, Bone.
[216] A. Forslund,et al. Growth hormone‐dependent insulin‐like growth factor binding protein is a major determinant of bone mineral density in healthy men , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[217] M. Kumegawa,et al. Insulin-like growth factor-I supports formation and activation of osteoclasts. , 1992, Endocrinology.
[218] J. Risteli,et al. Type I and III procollagen propeptides in growth hormone-deficient patients: effects of increasing doses of GH. , 1991, Acta endocrinologica.
[219] R. Pelker,et al. The influence of ibuprofen on fracture repair: Biomechanical, biochemical, histologic, and histomorphometric parameters in rats , 1991, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[220] D. Andress,et al. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. , 1992, The Journal of biological chemistry.
[221] J. Isgaard,et al. Growth hormone regulates the level of insulin-like growth factor-I mRNA in rat skeletal muscle. , 1989, The Journal of endocrinology.
[222] J. Kaufman,et al. Short and long‐term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone‐deficient males * , 1993, Clinical endocrinology.
[223] S. Mohan,et al. Studies on the Mechanisms by Which Insulin-like Growth Factor (IGF) Binding Protein-4 (IGFBP-4) and IGFBP-5 Modulate IGF Actions in Bone Cells (*) , 1995, The Journal of Biological Chemistry.
[224] J. Guevara-Aguirre,et al. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency. , 1997, The Journal of clinical endocrinology and metabolism.
[225] A. Bankier,et al. [Bone density of the lumbar spine and femur in acromegaly]. , 1993, Der Radiologe.
[226] A. Bellastella,et al. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects , 1996, Clinical endocrinology.
[227] S. Greenberg,et al. A direct growth effect of growth hormone in rat hindlimb shown by arterial infusion. , 1986, The American journal of physiology.
[228] J. Jowsey,et al. Osteoporosis in ovarian dysgenesis. , 1974, The Journal of pediatrics.
[229] M. Brada,et al. Bone mineralization after treatment of growth hormone deficiency in survivors of childhood malignancy , 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[230] S. Ortolani,et al. Effects of recombinant growth hormone (GH) treatment on bone mineral density and body composition in adults with childhood onset growth hormone deficiency , 1996, Journal of endocrinological investigation.
[231] C. Ohlsson,et al. Growth hormone receptor activity is stimulated by insulin-like growth factor binding protein 5 in rat osteosarcoma cells. , 1996, Growth regulation.
[232] H. Oxlund,et al. Qualitative alterations of cortical bone in female rats after long-term administration of growth hormone and glucocorticoid. , 1996, Bone.
[233] R. Pedowitz,et al. Tourniquet-induced neuromuscular injury. A recent review of rabbit and clinical experiments. , 1991, Acta orthopaedica Scandinavica. Supplementum.
[234] L. Mosekilde,et al. A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[235] H. Oxlund,et al. Glucocorticoid treatment or food deprivation counteract the stimulating effect of growth hormone on rat cortical bone strength , 1992, Acta paediatrica.
[236] H. Zeisel,et al. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. , 1990, The Journal of clinical endocrinology and metabolism.
[237] L. Powell-Braxton,et al. IGF-I is required for normal embryonic growth in mice. , 1993, Genes & development.
[238] G. Saggese,et al. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. , 1996, The Journal of clinical endocrinology and metabolism.
[239] R. McCARTER,et al. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. , 1985, The Journal of clinical endocrinology and metabolism.
[240] E. V. Koskinen. The repair of experimental fractures under the action of growth hormone, thyrotropin and cortisone. A tissue analytic, roentgenologic and autoradiographic study. , 1959, Annales chirurgiae et gynaecologiae Fenniae. Supplementum.
[241] C. Ohlsson,et al. Cortisol increases growth hormone-receptor expression in human osteoblast-like cells. , 1998, The Journal of endocrinology.
[242] S. P. Chow,et al. 25-Hydroxycholecalciferol and insulin-like growth factor I are determinants of serum concentration of osteocalcin in elderly subjects with and without spinal fractures. , 1990, Bone.
[243] L. Lönn,et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. , 1993, The Journal of clinical endocrinology and metabolism.
[244] W. Daughaday,et al. Somatomedin: Proposed Designation for Sulphation Factor , 1972, Nature.
[245] J. Tobias,et al. Opposite effects of insulin-like growth factor-I on the formation of trabecular and cortical bone in adult female rats. , 1992, Endocrinology.
[246] J. Aloia,et al. Skeletal alterations in hypophysectomized rats: II. A histomorphometric study on tibial cortical bone , 1995, The Anatomical record.
[247] A. Nilsson,et al. Systemically and locally administered growth hormone stimulates bone healing in combination with osteopromotive membranes: An experimental study in rats , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[248] R. Palmiter,et al. Dwarf mice produced by genetic ablation of growth hormone-expressing cells. , 1988, Genes & development.
[249] L. Mathews,et al. Regulation of insulin-like growth factor messenger ribonucleic acid in rat growth plate by growth hormone. , 1988, Endocrinology.
[250] C. Christiansen,et al. Effects of growth hormone (GH) on plasma bone Gla protein in GH-deficient adults. , 1990, The Journal of clinical endocrinology and metabolism.
[251] E. Froesch,et al. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[252] J. Guevara-Aguirre,et al. A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency. , 1995, The Journal of clinical endocrinology and metabolism.
[253] R. Clark,et al. Enhanced body growth in uremic rats treated with IGF-I and growth hormone in combination. , 1994, Kidney international.
[254] J. Aloia,et al. Effect of ovariectomy on cancellous bone in the hypophysectomized rat , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[255] G. Wong,et al. IGF‐I Production by Mouse Osteoblasts , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[256] P. Pietschmann,et al. Bone mineral density and parameters of bone metabolism in patients with acromegaly , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[257] H. Kruse,et al. On an Attempt to Treat Primary and Secondary Osteoporosis with Human Growth Hormone* , 1975, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[258] D. Rudman,et al. Effects of human growth hormone in men over 60 years old. , 1990, The New England journal of medicine.
[259] R. Baxter,et al. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. , 1993, The Journal of clinical investigation.
[260] F. Liu,et al. Further characterization of insulin-like-growth factor binding proteins in rat osteoblast-like cell cultures: modulation by 17 beta-estradiol and human growth hormone. , 1991, Endocrinology.
[261] P. Lips,et al. The effect of growth hormone on histomorphometric indices of bone structure and bone turnover in growth hormone deficient men , 1997 .
[262] S. Melmed,et al. Biochemical assessment of bone formation and resorption in acromegaly. , 1993, The Journal of clinical endocrinology and metabolism.
[263] A. Lindahl,et al. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. , 1987, Endocrine reviews.
[264] S. Mohan,et al. Growth hormone stimulates cortical bone formation in immature hypophysectomized rats. , 1992, Endocrine research.
[265] C. Christiansen,et al. Serum bone Gla protein: a potential marker of growth hormone (GH) deficiency and the response to GH therapy. , 1990, The Journal of clinical endocrinology and metabolism.
[266] J. Baker,et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.
[267] E. Koskinen. THE EFFECT OF GROWTH HORMONE AND THYROTROPIN ON HUMAN FRACTURE HEALING. A CLINICAL, QUANTITATIVE RADIOGRAPHIC AND METABOLIC STUDY. , 1963, Acta orthopaedica Scandinavica. Supplementum.
[268] K. Chihara,et al. Stimulatory effect of growth hormone on bone resorption and osteoclast differentiation. , 1996, Endocrinology.
[269] T. Abribat,et al. Long-term growth hormone-releasing factor administration on growth hormone, insulin-like growth factor-I concentrations, and bone healing in the Beagle. , 1996, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.
[270] B. Carlsson,et al. Expression and regulation of growth hormone (GH) receptor messenger ribonucleic acid (mRNA) in rat adipose tissue, adipocytes, and adipocyte precursor cells: GH regulation of GH receptor mRNA. , 1991, Endocrinology.
[271] L. Mosekilde,et al. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[272] Z. Laron,et al. Three Year IGF-I Treatment of Children with Laron Syndrome , 1995, Journal of pediatric endocrinology & metabolism : JPEM.
[273] J. De Schepper,et al. Comparative study of the changes in insulin-like growth factor-I, procollagen-III N-terminal extension peptide, bone Gla-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone. , 1990, The Journal of clinical endocrinology and metabolism.
[274] A. Prader,et al. Isolated growth hormone deficiency in prepubertal children. Influence of human growth hormone on longitudinal growth, adipose tissue, bone mass and bone maturation. , 1970, Helvetica paediatrica acta.
[275] A. Lindahl,et al. Effects of local administration of GH and IGF-1 on longitudinal bone growth in rats. , 1986, The American journal of physiology.
[276] L. Sjöström,et al. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. , 1996, The Journal of clinical endocrinology and metabolism.
[277] J. Ihle,et al. The Identification of JAK2 Tyrosine Kinase as a Signaling Molecule for Growth Hormone , 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[278] C. Ohlsson,et al. Growth hormone induces multiplication of the slowly cycling germinal cells of the rat tibial growth plate. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[279] C. Roberts,et al. Regulation of insulin-like growth factor I transcription by prostaglandin E2 in osteoblast cells. , 1995, Endocrinology.
[280] L. Underwood,et al. Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism). , 1991, The New England journal of medicine.
[281] A. O’Sullivan,et al. Sex steroid regulation of growth hormone secretion and action. , 1996, Hormone research.
[282] O. Nilsson,et al. Enhancement of bone formation in rabbits by recombinant human growth hormone. , 1993, Acta orthopaedica Scandinavica.
[283] R. Baxter,et al. Differential long-term effects of insulin-like growth factor-I (IGF-I) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats. , 1996, Endocrinology.
[284] P. Rotwein,et al. In vivo growth hormone treatment rapidly stimulates the tyrosine phosphorylation and activation of Stat3. , 1995, Molecular endocrinology.
[285] A. R. Baker,et al. Local expression of human growth hormone in bone results in impaired mechanical integrity in the skeletal tissue of transgenic mice , 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[286] R L Hintz,et al. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. , 1994, The Journal of clinical endocrinology and metabolism.
[287] E. Froesch,et al. Growth hormone and parathyroid hormone stimulate IGFBP-3 in rat osteoblasts. , 1994, The American journal of physiology.
[288] H. Pollard,et al. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. , 1994, Biochimica et biophysica acta.
[289] C. Boreham,et al. Growth hormone treatment of adults withgrowth hormone deficiency: results of a 13‐month placebo controlled cross‐over study , 1992, Clinical endocrinology.
[290] G. Rodan,et al. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. , 1989, Endocrinology.
[291] E. Eriksen,et al. Growth hormone, insulin‐like growth factors and bone remodelling , 1996, European journal of clinical investigation.
[292] D. Leroith. Insulin-like growth factor receptors and binding proteins. , 1996, Bailliere's clinical endocrinology and metabolism.
[293] I. Robinson,et al. Pubertal development and testicular function in the male growth hormone-deficient rat. , 1990, The Journal of endocrinology.
[294] H. Melhus,et al. Adult human osteoblast-like cells do not express insulin-like growth factor-I. , 1994, Biochemical and biophysical research communications.
[295] E. Canalis,et al. Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone. , 1991, Endocrinology.
[296] S. Mohan,et al. Evidence that human bone cells in culture secrete insulin‐like growth factor (IGF)‐II and IGF binding protein‐3 but not acid‐labile subunit both under basal and regulated conditions , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[297] C. Ohlsson,et al. Estrogen enhances growth hormone receptor expression and growth hormone action in rat osteosarcoma cells and human osteoblast-like cells. , 1997, The Journal of endocrinology.
[298] S. Ott. Editorial: Attainment of Peak Bone Mass , 1990 .
[299] J. Dequeker,et al. Effects of recombinant human growth hormone and insulin‐like growth factor‐I, with or without 17β‐estradiol, on bone and mineral homeostasis of aged ovariectomized rats , 1996 .
[300] D. Leroith,et al. Short-term effects of growth hormone and insulin-like growth factor I on cancellous bone in rhesus macaque monkeys. , 1997, The Journal of clinical endocrinology and metabolism.
[301] M. Preece,et al. Insulin-like growth factor I improves height in growth hormone insensitivity: two years' results. , 1995, Hormone research.
[302] M. Savage,et al. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. , 1996, The New England journal of medicine.
[303] W. Jee,et al. Bio‐assay of Responses of Growing Bones to Cortisol , 1966, Clinical orthopaedics and related research.
[304] H. Oxlund,et al. Human parathyroid hormone(1-34) increases bone formation and strength of cortical bone in aged rats. , 1994, European journal of endocrinology.
[305] E. Canalis,et al. Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. , 1989, Endocrinology.
[306] M. White,et al. Growth Hormone, Interferon-γ, and Leukemia Inhibitory Factor Utilize Insulin Receptor Substrate-2 in Intracellular Signaling* , 1996, The Journal of Biological Chemistry.
[307] M. Thorén,et al. Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteocalcin levels in adults with growth hormone deficiency. , 1993, Acta endocrinologica.
[308] L. Formigli,et al. Characterization and function of the receptor for IGF-I in human preosteoclastic cells. , 1996, Bone.
[309] W. Hayes,et al. Failure of growth hormone to alter the biomechanics of fracture-healing in a rabbit model. , 1992, The Journal of bone and joint surgery. American volume.
[310] P. Kelly,et al. The growth hormone/prolactin receptor family. , 1993, Recent progress in hormone research.
[311] R. Mazess,et al. Bone mineral status in growth hormone deficiency. , 1980, The Journal of pediatrics.
[312] S. Boonen,et al. Deficiency of the growth hormone-insulin-like growth factor-I axis potentially involved in age-related alterations in body composition. , 1996, Gerontology.
[313] S. Mohan,et al. Bone growth factors. , 1991, Clinical orthopaedics and related research.
[314] F. Melsen,et al. Parathyroid hormone (1-34) increases vertebral bone mass, compressive strength, and quality in old rats. , 1995, Bone.
[315] A. Tadmor,et al. The effect of growth hormone on the healing of experimental bone defects. , 1971, Acta orthopaedica Scandinavica.
[316] P. Delmas,et al. Insulin like growth factor I hormonal regulation by growth hormone and by 1,25(OH)2D3 and activity on human osteoblast-like cells in short-term cultures. , 1990, Bone.